MaRS Centre, 661 University Avenue, Suite 480
Toronto, Ontario, Canada, M5G 1M1
Pipeline
Our AI workbench is enabling the discovery of novel therapeutic targets for diseases with high unmet need.
| Target | Discovery | Preclinical | Phase 1/2 | Phase 3/Registration | |
|---|---|---|---|---|---|
MetabolicWilson Disease |
|||||
| DG12P1 | ATP7B M645R |
|
|||
| ATP7B SNV1 |
|
||||
| ATP7B SNV2 |
|
||||
| ATP7B SNV3 |
|
||||
| Undisclosed Metabolic | |||||
| DG11P1 | SNV1 |
|
|||
OphthalmologicUndisclosed Retinopathy |
|||||
| SNV1 |
|
||||
| SNV2 |
|
||||
| SNV3 |
|
||||
© 2019 DEEP GENOMICS. ALL RIGHTS RESERVED.